Objective:

To compare safety and oncological outcomes, specifically focusing on complication rates and recurrence rates, between microwave ablation (MW) and robot-assisted laparoscopic partial nephrectomy (RAPN) for clinical T1a renal cell carcinoma (RCC).

Key Findings:

• MW procedures had a higher median age, higher Charlson Comorbidity Index (CCI), and worse kidney function compared to RAPN, with p-values indicating statistical significance.
• Safety analyses included 68 patients for MW and 301 for RAPN, with complication rates of X% for MW and Y% for RAPN.
• Median follow-up was 2.4 years for MW and 3.7 years for RAPN, with recurrence rates of A% for MW and B% for RAPN.

Interpretation:

The study highlights differences in patient demographics and outcomes between MW and RAPN, suggesting that MW may be a viable alternative for patients unfit for surgery, potentially impacting treatment decisions.

Limitations:

• Retrospective design may introduce selection bias, limiting the generalizability of the findings.
• Cohorts were not directly comparable due to differences in baseline characteristics, which may affect outcome interpretation.

Conclusion:

MW may serve as an effective treatment option for T1a RCC in patients who are not suitable for RAPN, although further studies are needed to confirm these findings and address the limitations of this study.